Session Chair Profile

Chief Executive Officer, Cure Forward

Frank Ingari joined Cure Forward as CEO in 2016. Frank has served the consumer, healthcare and information technology industries for the past 35 years. He has held CEO appointments at NaviNet, 5-Star Medicare Advantage plan Essence Healthcare, and Best-in-KLAS Value-Based Care Service Provider Lumeris, which Ingari co-founded. As CEO of Navinet, Ingari was instrumental in driving strategic growth for the nation’s leading healthcare technology supplier of payer-provider collaboration solutions, culminating in a sale to NantHealth in January 2016.

Session Abstract

Session Synopsis: Patient engagement is rapidly emerging as a force that will shape the future of the healthcare industry. So why is patient participation/engagement important? This session – featuring a physician, a clinical trials operator, and a technology provider – will focus on the latest advancements and technologies that help with patient engagement, such as learning about molecular profiling tests, obtaining medical data, and finding the right clinical trial.